In this study, we investigated the causal relationship between enzymes in Glutathione metabolism and prostate cancer based on public databases; GSTP1 has the potential to serve as a biomarker for prostate cancer and may inhibit the development of prostate cancer through interactions between immune cells or upregulation of the P53 pathway and apoptosis. Here, GSTP1 is linked to prostate carcinoma.